Lpl Financial LLC Point Biopharma Global Inc. Transaction History

Lpl Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$6.67 - $9.71 $11,539 - $16,798	-1,730 Reduced 4.85%	33,925 $226,000
Q2 2023 Jul 31, 2023	SELL	$6.86 - $10.86 $353,187 - $559,127	-51,485 Reduced 59.08%	35,655 $323,000
Q1 2023 May 10, 2023	BUY	$6.78 - $8.1 $54,714 - $65,367	8,070 Added 10.21%	87,140 $633,000
Q3 2022 Nov 14, 2022	BUY	$7.24 - $10.31 $413,838 - $589,319	57,160 Added 260.89%	79,070 $611,000
Q2 2022 Aug 12, 2022	BUY	$5.6 - $9.5 $122,695 - $208,145	21,910 New	21,910 $149,000

20K

Ticker PNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 104,025,000
Description
POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.